Two Sigma Investments’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,015
Closed -$145K 3435
2025
Q1
$145K Sell
11,015
-797
-7% -$10.5K ﹤0.01% 2847
2024
Q4
$212K Sell
11,812
-1,099
-9% -$19.7K ﹤0.01% 2797
2024
Q3
$208K Buy
+12,911
New +$208K ﹤0.01% 2727
2023
Q2
Sell
-6,711
Closed -$280K 3140
2023
Q1
$280K Sell
6,711
-3,873
-37% -$161K ﹤0.01% 2372
2022
Q4
$359K Sell
10,584
-17,184
-62% -$583K ﹤0.01% 2112
2022
Q3
$1.37M Buy
27,768
+23,504
+551% +$1.16M ﹤0.01% 1291
2022
Q2
$168K Sell
4,264
-33,363
-89% -$1.31M ﹤0.01% 2128
2022
Q1
$1.39M Sell
37,627
-10,916
-22% -$403K ﹤0.01% 1494
2021
Q4
$4.75M Buy
48,543
+6,869
+16% +$672K 0.01% 925
2021
Q3
$5.2M Sell
41,674
-13,533
-25% -$1.69M 0.01% 882
2021
Q2
$6.92M Sell
55,207
-319
-0.6% -$40K 0.02% 780
2021
Q1
$7.54M Sell
55,526
-1,706
-3% -$232K 0.02% 682
2020
Q4
$5.2M Buy
57,232
+31,080
+119% +$2.82M 0.01% 718
2020
Q3
$1.95M Buy
26,152
+2,393
+10% +$178K 0.01% 918
2020
Q2
$2.02M Buy
23,759
+17,665
+290% +$1.5M 0.01% 870
2020
Q1
$441K Buy
6,094
+4,545
+293% +$329K ﹤0.01% 1299
2019
Q4
$111K Buy
1,549
+1,162
+300% +$83.3K ﹤0.01% 2045
2019
Q3
$20K Buy
+387
New +$20K ﹤0.01% 1895
2019
Q2
Sell
-6,171
Closed -$439K 2370
2019
Q1
$439K Sell
6,171
-512
-8% -$36.4K ﹤0.01% 1690
2018
Q4
$533K Buy
6,683
+3,124
+88% +$249K ﹤0.01% 1559
2018
Q3
$1.66M Buy
3,559
+669
+23% +$312K ﹤0.01% 1175
2018
Q2
$1.15M Buy
2,890
+849
+42% +$338K ﹤0.01% 1311
2018
Q1
$624K Buy
2,041
+45
+2% +$13.8K ﹤0.01% 1498
2017
Q4
$587K Buy
1,996
+259
+15% +$76.2K ﹤0.01% 1696
2017
Q3
$951K Buy
+1,737
New +$951K ﹤0.01% 1297